Next-generation sequencing can be used to continually assess and monitor risks in patients with leukaemia, a new proof-of-principle study has shown. The whole article was published by Chemistry World Magazine.
IMAGE: Ed Uthman — Flickr
Cancer progression and harmful bacteria tracked with next-generation sequencing